Murray W. Stewart

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects

M. Bush, M. Stewart, E. D. De Boever, 2009, Diabetes, obesity & metabolism.

Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes.

M. Bush, M. Stewart, E. D. De Boever, 2008, The Journal of clinical endocrinology and metabolism.